American Association for the Advancement of Science, Science Translational Medicine, 581(13), 2021
DOI: 10.1126/scitranslmed.abd8636
Full text: Unavailable
Neoantigens sensitize melanomas to checkpoint blockade and trigger epitope spreading to self-antigens, a process mimicked by combination immunotherapy.